| Affimer proteins are versatile and renewable affinity reagents C Tiede, R Bedford, SJ Heseltine, G Smith, I Wijetunga, R Ross, ... Elife 6, e24903, 2017 | 198 | 2017 |
| Expanding 3D geometry for enhanced on-chip microbubble production and single step formation of liposome modified microbubbles SA Peyman, RH Abou-Saleh, JR McLaughlan, N Ingram, BRG Johnson, ... Lab on a Chip 12 (21), 4544-4552, 2012 | 115 | 2012 |
| Engineering gold nanotubes with controlled length and near‐infrared absorption for Theranostic applications S Ye, G Marston, JR McLaughlan, DO Sigle, N Ingram, S Freear, ... Advanced Functional Materials 25 (14), 2117-2127, 2015 | 99 | 2015 |
| The omega‐3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC‐26 colorectal cancer cell liver metastasis via inhibition of PGE2‐dependent cell … G Hawcroft, M Volpato, G Marston, N Ingram, SL Perry, AJ Cockbain, ... British journal of pharmacology 166 (5), 1724-1737, 2012 | 65 | 2012 |
| Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and … N Ingram, LE McVeigh, RH Abou-Saleh, J Maynard, SA Peyman, ... Theranostics 10 (24), 10973, 2020 | 51 | 2020 |
| High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid cultures MD Bourn, DVB Batchelor, N Ingram, JR McLaughlan, PL Coletta, ... Journal of Controlled Release 326, 13-24, 2020 | 47 | 2020 |
| CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models JP Tiernan, N Ingram, G Marston, SL Perry, JV Rushworth, PL Coletta, ... Nanomedicine 10 (8), 1223-1231, 2015 | 46 | 2015 |
| Increasing the sonoporation efficiency of targeted polydisperse microbubble populations using chirp excitation J McLaughlan, N Ingram, PR Smith, S Harput, PL Coletta, S Evans, ... IEEE transactions on ultrasonics, ferroelectrics, and frequency control 60 …, 2013 | 45 | 2013 |
| The influence of intercalating perfluorohexane into lipid shells on nano and microbubble stability RH Abou-Saleh, SA Peyman, BRG Johnson, G Marston, N Ingram, ... Soft matter 12 (34), 7223-7230, 2016 | 42 | 2016 |
| Nanobubbles for therapeutic delivery: production, stability and current prospects DVB Batchelor, FJ Armistead, N Ingram, SA Peyman, JR Mclaughlan, ... Current Opinion in Colloid & Interface Science, 101456, 2021 | 41 | 2021 |
| Optimising gold nanorods for photoacoustic imaging in vitro OB Knights, S Ye, N Ingram, S Freear, JR McLaughlan Nanoscale Advances 1 (4), 1472-1481, 2019 | 41 | 2019 |
| Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer S Satheesha, VJ Cookson, LJ Coleman, N Ingram, B Madhok, AM Hanby, ... Molecular cancer 10 (1), 1-10, 2011 | 39 | 2011 |
| Poly (amino acid)-polyester graft copolymer nanoparticles for the acid-mediated release of doxorubicin DJ Price, M Khuphe, RPW Davies, JR McLaughlan, N Ingram, ... Chemical Communications 53 (62), 8687-8690, 2017 | 26 | 2017 |
| Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo TJ Harvey, IM Hennig, SD Shnyder, PA Cooper, N Ingram, GD Hall, ... Cancer Gene Therapy 18 (11), 773-784, 2011 | 25 | 2011 |
| Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min/+ mouse model of intestinal tumorigenesis MA Hull, RJ Cuthbert, CWS Ko, DJ Scott, EJ Cartwright, G Hawcroft, ... Scientific reports 7 (1), 1-14, 2017 | 24 | 2017 |
| Development of orthotopic tumour models using ultrasound-guided intrahepatic injection LE McVeigh, I Wijetunga, N Ingram, G Marston, R Prasad, AF Markham, ... Scientific reports 9 (1), 1-9, 2019 | 23 | 2019 |
| Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case … N Ingram, EL Northwood, SL Perry, G Marston, H Snowden, JC Taylor, ... Carcinogenesis 34 (10), 2341-2349, 2013 | 23 | 2013 |
| Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy N Ingram, CD Porter Gene therapy 12 (13), 1058-1069, 2005 | 23 | 2005 |
| Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor TJ Harvey, D Burdon, L Steele, N Ingram, GD Hall, PJ Selby, RG Vile, ... Gene therapy 17 (8), 1000-1010, 2010 | 20 | 2010 |
| Evaluating Phospholipid‐Functionalized Gold Nanorods for In Vivo Applications L Roach, ME Booth, N Ingram, DA Paterson, DVB Batchelor, ... Small 17 (13), 2006797, 2021 | 18 | 2021 |
